Imbrium Therapeutics Revenue

Biotechnology Research • Stamford, Connecticut, United States • 21-50 Employees

Imbrium Therapeutics revenue & valuation

Annual revenue	$2,566,650
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$8,300,000
Total funding	No funding

Key Contacts at Imbrium Therapeutics

Sara Draper

Director, Analytical Research And Development

Greg Sparta

Executive Director Regulatory Affairs

David Igo

Executive Director, Pharmaceutics And Analytical Development

Ronnie Ortiz

Director, Pharmaceutics

Rashmi Upasani

Director, Regulatory Strategy

Monica Leipold

Executive Director Of Strategic Projects & Business Initiatives

Jacqueline Nelson

Director, U.S. Regulatory Affairs

Alessandra Cipriano

Sr. Director

Evangeline Priya Eddy

Assoc Director, Toxicology

Company overview

Headquarters	201 Tresser Boulevard, Stamford, CT 06901, US
Phone number	+18888270622
Websites	imbriumthera.com pharma.com
NAICS	541714
SIC	283
Founded	2018
Employees	21-50
Socials

Imbrium Therapeutics Email Formats

Imbrium Therapeutics uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@imbriumthera.com), used 85.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@imbriumthera.com	85.7%
{second initial}.{last name}	o.doe@imbriumthera.com	7.1%
{first name}.{last name}	john.doe@imbriumthera.com	7.1%

About Imbrium Therapeutics

Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. We are pursuing oncology chemotherapeutics, treatments for disorders of the central nervous system, and non-opioid approaches to the management of pain. As an operating subsidiary of Purdue Pharma L.P., Imbrium strives to develop and bring to market new medicines that serve the unmet needs of patients, physicians and health systems worldwide. We have built a robust and diversified pipeline of investigational drug candidates, and we actively collaborate with industry and academic partners to identify and advance future impactful medicines. LinkedIn posts may include discussion of investigational products that have not been approved by FDA, and for which safety or effectiveness have not been established. There is no guarantee they will successfully complete development or gain FDA approval.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Entry

Manager

Employees by Department

Imbrium Therapeutics has 13 employees across 5 departments.

Departments

Number of employees

Funding Data

Imbrium Therapeutics has never raised funding before.

Imbrium Therapeutics Tech Stack

Discover the technologies and tools that power Imbrium Therapeutics's digital infrastructure, from frameworks to analytics platforms.

jQuery CDN

CDN

Wistia

Video players

Microsoft 365

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Bootstrap

UI frameworks

Yoast SEO

SEO

Draftpress HFCM

WordPress plugins

Frequently asked questions

Imbrium Therapeutics is located in Stamford, Connecticut, US.

You can reach Imbrium Therapeutics at +18888270622.

Imbrium Therapeutics generates an estimated annual revenue of $2,566,650. This revenue figure reflects the company's market position and business performance in its industry.

Imbrium Therapeutics has an estimated valuation of $8,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Imbrium Therapeutics was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Imbrium Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.